Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 908,144	$ 1,137,303
Trade accounts receivable, less allowance for doubtful accounts (2018 – $8,645; 2017 – $10,425)	571,032	534,326
Other accounts receivable	44,451	37,937
Inventories	665,522	592,781
Other current assets	93,921	136,064
Assets held for sale	0	39,152
Total current assets	2,283,070	2,477,563
Property, plant and equipment, at cost	4,375,335	4,124,335
Less accumulated depreciation and amortization	1,705,675	1,631,025
Net property, plant and equipment	2,669,660	2,493,310
Investments	519,518	534,064
Noncurrent assets held for sale	0	139,813
Other assets	75,108	74,164
Goodwill	1,585,500	1,610,355
Other intangibles, net of amortization	405,507	421,503
Total assets	7,538,363	7,750,772
Current liabilities:
Accounts payable	460,442	418,537
Accrued expenses	272,555	268,336
Current portion of long-term debt	208,681	422,012
Dividends payable	36,220	35,165
Liabilities held for sale	0	1,938
Income taxes payable	63,763	54,937
Total current liabilities	1,041,661	1,200,925
Long-term debt	1,406,724	1,415,360
Postretirement benefits	51,936	52,003
Pension benefits	281,421	294,611
Noncurrent liabilities held for sale	0	614
Other noncurrent liabilities	553,129	599,174
Deferred income taxes	366,212	370,389
Commitments and contingencies (Note 10)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, issued and outstanding – 108,441 in 2018 and 110,547 in 2017	1,084	1,105
Additional paid-in capital	1,609,526	1,863,949
Accumulated other comprehensive loss	(301,679)	(225,668)
Retained earnings	2,384,645	2,035,163
Total Albemarle Corporation shareholders’ equity	3,693,576	3,674,549
Noncontrolling interests	143,704	143,147
Total equity	3,837,280	3,817,696
Total liabilities and equity	$ 7,538,363	$ 7,750,772